We next assessed the in vivo efficacy of AAV-transduced hCAR-Vβ2 T cells using PDX NSG mice prepared by transferring primary total CD4 T cells isolated from a Vβ2+ PTCL patient. This evidence concerns the gene CD4 and mature T-cell and NK-cell non-Hodgkin lymphoma.